Clinical Trials Sponsored by FUNDACIÓN SAYANI

Total 2448 results

Fundación Neumologica Colombiana
Universidad de la Sabana

Unknown

Clinical Trial of a Rehabilitation Device Based on Electrostimulation for Obstructive Sleep Apnoea

Obstructive Sleep Apnoea

Colombia
Fundación Neumologica Colombiana
Universidad de la Sabana; Fundación Cardioinfantil Instituto de Cardiología; Clínica...

Completed

Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons. (SabanaHerons)

Covid19

Colombia
Universidad de la Sabana
Fundación Neumologica Colombiana; Stem Medicina Regenerativa; Innocell SAS

Available

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Pulmonary Fibrosis | Pulmonary Hypertension | Systemic Sclerosis Pulmonary

Colombia
Samyang Biopharmaceuticals Corporation

Not yet recruiting

A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement

Nasolabial Folds
Samyang Biopharmaceuticals Corporation

Completed

A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies

Advanced Solid Malignancies

Korea, Republic of
Samyang Biopharmaceuticals Corporation

Completed

Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer (DOPNP201)

Solid Tumor
Samyang Biopharmaceuticals Corporation

Completed

Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)

Hyperlipidemia

Korea, Republic of
Fundación GECP

Recruiting

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy (MERIT-lung)

Non-small Cell Lung Cancer Stage III | KRAS P.G12C

Spain
Fundación EPIC

Recruiting

Essential Pro PMCF Study ( rEPIC04E ) (rEPIC04E)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación GECP

Recruiting

Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases (NIVIPI-Brain)

Lung Cancer | Non Small Cell Lung Cancer | Brain Metastases, Adult

Spain
Fundación GECP

Recruiting

Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma (BIMES)

Mesothelioma; Lung

Spain
Fundación EPIC

Recruiting

ANGiographic Evaluation of Left Main Coronary Artery INtErvention (ANGELINE)

Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery Stenosis

Spain
Fundación GECP

Recruiting

Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Non Small Cell Lung Cancer | EGFR Gene Mutation

Spain
Fundación EPIC

Active, not recruiting

Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR (iLITRO)

Coronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, Coronary

Spain
Fundación EPIC

Completed

NAVISCORE PMCF Study ( rEPIC04F ) (rEPIC04F)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación GECP

Active, not recruiting

New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy (NADIM-ADJUVANT)

Non-Small Cell Lung Cancer | Adjuvant Chemotherapy

Spain
Fundación EPIC

Completed

Laser-excimer Versus High-pressure Dilation to Treat Under-expansion of the Stent (LASER EXPAND)

Cardiovascular Diseases | Arterial Disease

Spain
Fundación GECP

Active, not recruiting

Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients (CUBIK)

NSCLC | Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB

Spain
Fundación EPIC

Completed

Xperience Pro PMCF Study (rEPIC04A)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación Campbell

Completed

Medial Tab Flap for Soft Tissue Defects of the Leg

Leg Coverage Defects

Colombia
Fundación EPIC

Active, not recruiting

Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile (Monitor- ACS)

Heart Diseases | Atrial Fibrillation | Arrhythmias, Cardiac | Syncope | Tachycardia

Spain
Fundación GECP

Completed

Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients (VAC-CaP)

Covid19 | Lung Cancer

Spain
Fundación EPIC

Active, not recruiting

Registry of Coronary Lithotripsy in Spain. (REPLICA)

Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Arteriosclerosis | Arterial Occlusive Diseases

Spain
Fundación GECP

Completed

Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive (OSIREX)

Non Small Cell Lung Cancer

Spain
Fundación EPIC

Active, not recruiting

PRospective Evaluation Complementing Investigation With Acurate Neo Device (PRECISA)

Aortic Stenosis

Spain
Fundación Senefro

Completed

Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations (ACERCA)

ANEMIA

Spain
Fundación EPIC

Recruiting

Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

Coronary Artery Disease

Spain
Fundación EPIC

Recruiting

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Aortic Valve Stenosis | Structural Valve Deterioration

Spain
Fundación GECP

Recruiting

DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors (DUMAS)

NSCLC | Pancoast Tumor

Spain
Fundación GECP

Recruiting

Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer (PEERS)

Small Cell Lung Cancer Extensive Stage

Spain
Fundación GECP

Recruiting

Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment (REAL-NADIM)

Neoadjuvant Treatment | Non Small Cell Lung Cancer Stage III

Spain
Fundación EPIC

Recruiting

ANGIOLITE PMCF Study ( rEPIC04F ) (rEPIC04F)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

CAPTURER PMCF Study ( rEPIC04D ) (rEPIC04D)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación GECP

Recruiting

Pathological Response After Neoadjuvant Treatment on NSCLC (PLANET)

Stage IIIA Non-small Cell Lung Cancer

Spain
Fundación IVI

Recruiting

Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy) (hSCU-PRP)

Asherman Syndrome | Endometrial Atrophy

Spain
Fundación IVI

Recruiting

Comparison of ICSI Outcomes in Cycles Using Testicular and Ejaculate Sperm From Couples With High SDF

DNA Damage | IVF | Oligospermia | ICSI | Embryo

Spain
Fundación GECP

Recruiting

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) (APOLO)

Lung Diseases | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Carcinoma Bronchiogenic Stage III

Spain
Fundación EPIC

Recruiting

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction

Spain
Fundación EPIC

Recruiting

Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm) (RETO 320)

Coronary Artery Disease

Spain
Fundación IVI

Recruiting

Use of PRP in Endometrial Reconstruction

Asherman Syndrome | Endometrial Atrophy

Spain
Fundación GECP

Active, not recruiting

Atezolizumab Plus Bevacizumab in First Line NSCLC Patients (TELMA)

Non Small Cell Lung Cancer

Spain
Fundación EPIC

Active, not recruiting

A Prospective Study, Single-arm, Multicentre, Observational to Evaluate Safety and Effectiveness of Stent Ultimaster Tansei Coronary Stent in Complex Coronary Lesions. (TANSEI)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación GECP

Completed

Efficacy & Safety Study of Lorlatinib in ALK/ROS1 Metastatic NSCLC Patients With Compassionate Use Treatment (LORLAPULM)

Metastatic Non Small Cell Lung Cancer

Spain
Fundación EPIC

Completed

Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis (WATCH-HD)

Heart Diseases | Cardiovascular Diseases | Atrial Fibrillation | Bleeding | Arrhythmias, Cardiac | Renal Disease

Spain
Fundación EPIC

Completed

Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study (SIERRA 75)

Coronary Artery Disease | Ischemic Heart Disease

Spain, Portugal
Fundación Senefro

Unknown

Study to Explore Morbimortality in Patients Dialyzed With the Theranova HDx in Comparison to On-Line-Hemodiafiltration

Chronic Kidney Disease Requiring Chronic Dialysis

Spain
Fundación EPIC

Recruiting

PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients (PARIS)

Coronary Artery Disease

Spain
Fundación EPIC

Not yet recruiting

Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)

Coronary Disease
Fundación EPIC

Recruiting

Comparison Between Optical Coherence Tomography and Intravascular Ultrasound for Intermediate Left Main Coronary Artery Lesions (EMPERATRIZ)

Coronary Disease

Spain
Fundación GECP

Recruiting

Characteristics of Sexual Dysfunction in Patients With Lung Cancer (LUDICAS)

Sexual Dysfunction | Lung Cancer

Spain, Portugal, Argentina, Colombia, Peru

3

Subscribe